As the Shanghai Science and Technology Collaborative Innovation Center led by Shanghai Jiao Tong University School of Medicine and relying on the materialization of the Ninth People's Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Precision Medicine was at the Shanghai Jiuyuan Hospital at 115 Jinzun Road, Pudong New Area this morning. The Science and Education Park was formally established and unveiled. According to Lei Ming, Executive Dean of the Shanghai Institute of Precision Medicine, the Shanghai Institute of Precision Medicine will form a platform through the construction of an electron microscope platform, a bio-imaging platform, a data calculation and analysis platform, a omics platform, a protein platform, and a chemical biology platform. Comprehensive technical platform for protein preparation and characterization, high-resolution structural analysis, multi-omics analysis, high-resolution bio-imaging, and high-performance computing capabilities. On this basis, we will also work with clinical institutions to establish a scientific research cooperation network that complements scientific research data sharing, technology joint articulation and research fields, focusing on stem cells and regenerative medicine, pathogenic microorganisms, reproductive and genetic development, tumor and metabolic diseases, and groups. Studies, structural biology, bioinformatics and other research fields closely related to precision medicine truly promote the precise prevention and precise treatment of diseases. The Shanghai Institute of Precision Medicine plans to have a total staff size of about 120 in five years, and eventually build a precision medical research base with global influence. Wu Hao, dean of the Shanghai Ninth People's Hospital and dean of the Shanghai Institute of Precision Medicine, said that the Shanghai Institute of Precision Medicine will use precision medicine as its core competitiveness to link basic pharmaceutical research and clinical applications with international pharmaceutical giants and technological innovation companies in Zhangjiang. And the seamless connection of new drug research and development, and on this basis, catalyze the efficient transformation of a large number of cutting-edge scientific discoveries into the medical entity economy, and jointly promote the development of the innovative economy of Pudong New Area, and finally become one of the first-class precision medical research, medical and education centers in China. In the field of health care, we will create two major business cards, Shanghai Service and Shanghai Manufacturing, to contribute to the construction of a globally influential and innovative city in Shanghai. Chen Guoqiang, academician of the Chinese Academy of Sciences and dean of the School of Medicine of Shanghai Jiaotong University, served as the director of the first academic/expert advisory committee of the Shanghai Institute of Precision Medicine. He said that the Shanghai Institute of Precision Medicine will target chronic diseases such as cancer, metabolic diseases, neurodegenerative diseases and cardiovascular diseases that are serious threats to human health, based on individual genetic background, environmental factors, and lifestyle. Based on the big data of living habits, the key breakthroughs are to achieve precise prevention, diagnosis and treatment with certain points, so that certain fields can enter the international leading stage and substantially improve the level of Shanghai medical disciplines; generate some innovative products of precision medicine to support Shanghai Pharmaceuticals. The transformation and development of the health industry; innovation and institutional mechanisms have become the demonstration base for Shanghai to build a global science and technology innovation center, and ultimately promote the economic development of the city and the improvement of people's well-being. Precision medicine has evolved with the rapid advancement of genome sequencing technology and the cross-application of bioinformatics and big data science. It is a new medical concept and medical model based on individualized medicine. The key is the combination of genetic information, diagnosis and treatment, which makes the diagnosis and treatment of diseases more targeted, targeted and specific. Its essence is the analysis, identification, verification and application of biomarkers for large sample populations and specific disease types through genomics, proteomics and other omics techniques and medical frontier technologies, so as to accurately find the cause of the disease and the target of treatment. Point, and accurately classify the different states and processes of the disease, and finally achieve the purpose of personalized and precise treatment for diseases and specific patients, and improve the effectiveness of disease diagnosis and treatment. (Xinmin Evening News)
China Thickening Agent Suppliers
Here you can find the related products in Thickening Agent, we are professional manufacturer of Thickening agent. We focused on international export product development, production and sales. We have improved quality control processes of Thickening Agent to ensure each export qualified product.
If you want to know more about the products in Thickening Agent, please click the Product details to view parameters, models, pictures, prices and Other information about Thickening Agent.
Whatever you are a group or individual, we will do our best to provide you with accurate and comprehensive message about Thickening Agent!
Transglutaminase, Chitosan, Guar Gum, Gelatin, Arabic Gum, Xanthan Gum Xi'an Gawen Biotechnology Co., Ltd , https://www.ahualynbios.com
Shanghai Institute of Precision Medicine unveiled a globally influential precision medical research base
Next Article
How to do bloating